Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker MIRM
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 3, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 13, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 8, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 5, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| May 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| May 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 4, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 27, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 25, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Jan 12, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 19, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 19, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 19, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 19, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 8, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 8, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 8, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 8, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 30, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2024 | MIRM Mirum Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
38 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:56 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances